Table 2 Outcome data
N (%) | |
|---|---|
Control of bleeding | |
Uncontrolled | 3 |
Re-bleeding | 2 (1 stent displaced–1 post-stent removal) |
controlled | 23 (82%) |
6 weeks survival (deceased/alive) | 7/21 (75%) |
Stent displaced | 6 (21.43%) (1 re-stent and 3 re-positioned) |
Stent-related complications (no. 4) | 2 aspiration |
2 aspiration bronchopneumonia | |
Development of encephalopathy post-endoscopy (no. 9) | 9 (32.1%) |
Covert | 3 |
Overt | 6 |
6 weeks cause related mortality (no. 7) | |
Bleeding | 4 (14.3%) |
Sepsis | 1 |
MOF | 2 |
Rescue therapy | 2 sungestaken tubes (1 deceased) |